3tcp
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569== | ==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569== | ||
<StructureSection load='3tcp' size='340' side='right' caption='[[3tcp]], [[Resolution|resolution]] 2.69Å' scene=''> | <StructureSection load='3tcp' size='340' side='right' caption='[[3tcp]], [[Resolution|resolution]] 2.69Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3tcp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3tcp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TCP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3TCP FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CKJ:1-[(TRANS-4-AMINOCYCLOHEXYL)METHYL]-N-BUTYL-3-(4-FLUOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE'>CKJ</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CKJ:1-[(TRANS-4-AMINOCYCLOHEXYL)METHYL]-N-BUTYL-3-(4-FLUOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE'>CKJ</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3bpr|3bpr]], [[2brb|2brb]], [[2poc|2poc]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3bpr|3bpr]], [[2brb|2brb]], [[2poc|2poc]]</td></tr> | ||
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MERTK, MER ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">MERTK, MER ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3tcp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3tcp OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3tcp RCSB], [http://www.ebi.ac.uk/pdbsum/3tcp PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3tcp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3tcp OCA], [http://pdbe.org/3tcp PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3tcp RCSB], [http://www.ebi.ac.uk/pdbsum/3tcp PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3tcp ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 21: | Line 22: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 3tcp" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
Line 28: | Line 30: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Human]] |
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
[[Category: DeRyckere, D]] | [[Category: DeRyckere, D]] |
Revision as of 13:31, 11 August 2016
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569
|
Categories: Human | Receptor protein-tyrosine kinase | DeRyckere, D | Deusen, A Van | Earp, H S | Frye, S | Graham, D K | Hunter, D | Janzen, W P | Johnson, G | Kireev, D B | Liu, J | Machius, M | Miley, M | Norris-Drouin, J | Patel, H S | Sather, S | Simpson, C | Wang, X | Yang, C | Acute lymphoblastic leukemia | Rational structure-based drug design | Transferase-transferase inhibitor complex | Tyrosine kinase